Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
Clinical trial NCT03057106 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03057106
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2020-02-24
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.